How do systemic conditions such as liver disease affect the choice of local anesthetic?

• A. Amide LAs are hepatically metabolized; liver disease may require dose adjustments or alternative agents.
• B. Ester LAs are hepatically metabolized; liver disease has no effect.
• C. All LAs are contraindicated in liver disease.
• D. Liver disease accelerates the metabolism of all LAs equally.

Answer: (A)

Systemic conditions like liver disease affect how local anesthetics are processed in the body. Amide local anesthetics are cleared primarily by the liver. When liver function is impaired, their metabolism slows, leading to higher blood levels and a greater risk of systemic toxicity. Because of that, clinicians often reduce the dose, extend intervals between repeats, or choose an agent with a different metabolic pathway.

Esters, in contrast, are mainly broken down by plasma cholinesterases rather than the liver, so liver disease tends to have less impact on their clearance. That’s why, in patients with significant liver dysfunction, an amide’s dose may need adjustment or an alternative agent may be considered, while awareness and monitoring remain important for all patients.